Skip to main navigation
BACK TO CORPORATE SITE

Investor Relations

  • INVESTOR RELATIONS
  • RELEASES
  • DOWNLOAD CENTER
  • CALENDAR
  • FINANCIAL INFORMATION
    • OUTLOOK
  • STOCK INFORMATION
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ORDER DEPTH AND LATEST TRADES
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • CORPORATE GOVERNANCE
    • GOVERNANCE DOCUMENTS
    • RISK MANAGEMENT
    • REPORTING COMPLIANCE VIOLATIONS AND CONCERNS
    • VELOXIS AS WHISTLEBLOWER POLICY
    • WHISTLEBLOWING GUIDELINES FOR REPORTED EMPLOYEES
  • GENERAL MEETINGS

Financial Highlights

highlights

STOCK INFORMATION

Last Price
Change %
Market Cap
Updated img
LATEST RELEASES
Aug 31, 2018
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 August 2018
Aug 23, 2018
Veloxis Increases Share Capital in Connection with Exercise of Warrants
Aug 13, 2018
Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2018
Jul 13, 2018
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

Veloxis Pharmaceuticals A/S | c/o Plesner Advokatpartnerselskab | Amerika Plads 37 | 2100 København Ø | CVR-no. 26 52 77 67 | info@veloxis.com